UNSPSC 51401559: Camazepam

This classification denotes a benzodiazepine tranquilizer and temazepam analog with the molecular formula C19H18ClN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HZ3XRH03C3, chemically known as 7-chloro-1,3-dihydro-3-(n,n-dimethylcarbamoyl)-1-methyl-5-phenyl-2h-1,4-benzodiazepin-2-one but generally known as camazepam, which bears US NIH Compound Identifier 37367. European Medicines Agency schedules Camazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06061MIG.

UNSPSC 51401559 Camazepam, a Commodity code, nominally addresses pharmaceutical products; however, recent state and local solicitation activity shows no actual procurement of this substance. The most recent tagged opportunity under this code is a Seminole County, Florida IFB for naloxone and drug deactivation systems — products unrelated to camazepam's therapeutic scope. State and local procurement records do not reflect current buying activity that matches the code's stated commodity classification.

Seminole County's IFB 60459723LAS, posted June 30, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023. No additional representative opportunities under this code appear in current state and local records, and the geographic and issuing-body pattern cannot be characterized from available data. The mismatch between the code's nominal scope and the single recent opportunity tagged to it suggests this Commodity code may see limited or misclassified procurement activity in state and local markets.